Title : Sacubitril/Valsartan: From Clinical Trials to Real-world Experience.

Pub. Date : 2018 Apr 23

PMID : 29687191






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PURPOSE OF REVIEW: Compared to enalapril, use of angiotensin-receptor blocker and neprilysin inhibitor sacubitril/valsartan to treat patients with heart failure and reduced ejection fraction (HFrEF) is associated with substantial reductions in both cardiovascular mortality and heart failure progression. Valsartan membrane metalloendopeptidase Homo sapiens